Cipla Ltd

Type: Company
Name: Cipla Ltd
Nationality: India
Web Address: http://www.cipla.com/
Fact Sheet: Fact Sheet for Cipla Ltd
First reported 5 hours ago - Updated 4 mins ago - 2 reports

Sensex, Nifty hit fresh record high

Indian equities are trading higher with Sensex and Nifty at their new highs on Tuesday. Healthcare and realty stocks witnessed a gain whereas capital goods stocks registered a fall.At 10.25 a.m., the Sensex was trading up 46.63 points or 0.17% at 26,914.18. ... [Published MyIris - 3 hours ago]
First reported 41 mins ago - Updated 41 mins ago - 1 reports

Book profits on Cipla: Ashwani Gujral

In a chat with ET Now, Ashwani Gujral, Fund Manager, Ashwanigujral.com, shares his view on markets and few stocks. Excerpts: ET Now: How do you look at these life highs for the index?Ashwani Gujral: First, just a word on Cipla because today I have heard ... [Published Economic Times - 41 mins ago]
Entities: Cipla Ltd, Stocks, Index
First reported 5 hours ago - Updated 1 hour ago - 14 reports

Cipla firm but off highs on BSE

Cipla maintained its firm undertone but was off its morning highs ahead of the close on the BSE on Tuesday. At 2.55 pm the stock was trading at ₹559.20, up 5.57 per cent on its previous close at ₹529.70.The stock hit record highs today after it received ... [Published Hindu Business Line - 1 hour ago]
First reported 5 hours ago - Updated 1 hour ago - 3 reports

BSE Sensex above 27,000 level

At 3:11PM: The S&P BSE Sensex is trading at 27,013, up 146 points, while NSE Nifty is trading at 8,077, up 49 points.The Sensex has gained over 2,000 points since the new government has come to power in May, 2014.The BSE Mid-cap index is trading up 0.83% ... [Published India Infoline - 1 hour ago]
First reported 22 hours ago - Updated 1 hour ago - 17 reports

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

Indian generic drugmaker Cipla has entered the respiratory market in Germany and Sweden with its Serroflo (salmeterol/fluticasone MDI).Serroflo is the generic version of UK pharma major GlaxoSmithKline (LSE: GSK)’s Advair, and aside from Croatia where ... [Published Pharma Letter - 1 hour ago]
First reported 4 hours ago - Updated 2 hours ago - 2 reports

BRIEF: Cipla shares jump 8.6% on launch of its generic asthma drug [Mint, New Delhi :: ]

Sept. 02--MUMBAI -- Shares of Cipla LtdCipla's drug will be marketed under the name Serrofloin in Germany and Salmeterol/Fluticasone Cipla in Sweden.The company on Monday said that it launched an anti-asthma inhaler in Germany and Sweden that is a generic ... [Published BusinessWeek - 2 hours ago]
First reported Sep 01 2014 - Updated 3 hours ago - 10 reports

Cipla hits record high

Cipla jumped 6.87% to Rs 566.10 at 10:47 IST on BSE on reports the company has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair.Meanwhile, the S&P BSE Sensex was up 87.09 points or 0.32% at ... [Published Capital Market - 3 hours ago]
First reported 4 hours ago - Updated 4 hours ago - 1 reports

CIMB sees earnings upgrade for Cipla in FY16

CThe house has a target price of Rs 600 on the stock valued at 21 times one-year forward, says Agarwal. The entire EU inhaler market is around USD 800 million in Europe, he adds.Earlier the stock touched a record high post its launch of generic drug used ... [Published Moneycontrol.com - 4 hours ago]
First reported Sep 01 2014 - Updated 6 hours ago - 5 reports

Sensex, Nifty Continue Record-Breaking Spree

BSE Sensex and Nifty rose today to fresh record highs amid optimism over recovery in the Indian economy after the first quarter growth surged to nine-quarter high.Sensex and Nifty clocked fresh record highs of 26,952 and 8,055 today.Foreign investors, ... [Published NDTV - 6 hours ago]
First reported Sep 01 2014 - Updated 6 hours ago - 3 reports

Sensex modestly higher after hitting new high; Cipla gains nearly 7%

The BSE benchmark Sensex is slowly inching its way towards the 27,000 mark, with stocks opening on a firm note this morning, despite mixed global cues.After hitting a new high of 26,952.88, the Sensex is now up 33.55 points or 0.12% at 26,901.10. The ... [Published Sify - 6 hours ago]
First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

See upside in Cipla, says Sukhani

S"I think there is more upside here. Cipla is the highest risk and highest reward stock," he added. ... [Published Moneycontrol.com - Sep 01 2014]
Entities: Cipla Ltd, Risk
First reported Aug 31 2014 - Updated Sep 01 2014 - 2 reports

Ranbaxy now a mid-cap stock

Ranbaxy Laboratories, which was the country's largest pharmaceutical company in terms of FY14 sales numbers, will figure in the CNX mid-cap index from September 26. Until March this year, the company was part of the benchmark Nifty index. The 50-share ... [Published Smart Investor - Sep 01 2014]

Quotes

"There are still enough and more opportunities. Infrastructure as an area, real estate as an area, the entire power sector as an area still is a long-long way to go and these will go on the back of the reforms, on the back of removal of the bottlenecks which have been plaguing these sectors" he added
Ashish Rathi, research analyst, Emkay Global Financial Services, said, "Cipla launches first combination inhaler Serroflo in two European countries (Germany and Sweden). We believe growth trajectory ahead remains interesting and incremental launches pose upside risks to our numbers. We upgrade to Buy from Accumulate with TP of Rs 671."
"We raise our target price to Rs 610 (Rs 600 earlier) as we now build in 100 per cent probability of success for Advair pMDI in EU-5 countries, and see several other triggers to drive further re-rating over the next 12-18 months" the report added
"This is going to be one of the major growth drivers for Cipla" which will be first to market in Europe with substitutable generic Advair, Mr Mehta said

More Content

All (722) | News (691) | Reports (0) | Blogs (24) | Audio/Video (0) | Fact Sheets (5) | Press Releases (1)
sort by: Date | Relevance
Sensex ends past 27,000-mark for first time; Ni... [Published Economic Times - 28 mins ago]
Book profits on Cipla: Ashwani Gujral [Published Economic Times - 41 mins ago]
Cement stocks hold firm up on NSE [Published Hindu Business Line - 56 mins ago]
Cipla firm but off highs on BSE [Published Hindu Business Line - 1 hour ago]
BSE Sensex above 27,000 level [Published India Infoline - 1 hour ago]
Sensex holds above 27,000 [Published Sify - 1 hour ago]
Cipla's generic of GSK's Advair for asthma mark... [Published Pharma Letter - 1 hour ago]
Approval in Germany and Sweden lifts Cipla’s stock [Published Hindu Business Line - 1 hour ago]
Markets hit fresh record highs; Nifty tops 8,100 [Published Business Standard India - 1 hour ago]
Nifty hits 8,100; BSE Healthcare Index up 1.15% [Published India Infoline - 1 hour ago]
Sensex moves past 27,000 [Published Business Standard India - 2 hours ago]
Cipla stock surges 6% [Published India Infoline - 2 hours ago]
Sensex, Nifty hit record highs; Cipla, Bharti A... [Published BusinessWeek - 2 hours ago]
BRIEF: Cipla shares jump 8.6% on launch of its ... [Published BusinessWeek - 2 hours ago]
Sensex breaches 27,000-mark; Nifty at record hi... [Published IBNLive India News - 2 hours ago]
Sensex crosses 27,000 mark [Published Sify - 2 hours ago]
BSE Sensex logs new record high; rises past 27,... [Published zeenews.com - 2 hours ago]
BSE Sensex rises past 27,000 to mark latest record [Published Reuters India - 3 hours ago]
Sensex, Nifty at new high; pharma shares lead [Published Business Today India - 3 hours ago]
Cipla hits record high [Published Capital Market - 3 hours ago]
Cipla shares surge nearly 9%; top gainer on Sen... [Published Business Standard India - 3 hours ago]
Cipla shares surge 9%; top gainer on Sensex, Nifty [Published Press Trust of India - 3 hours ago]
Sensex inches towards 27000; HDFC twins, pharma... [Published Moneycontrol.com - 3 hours ago]
Here are top buzzing stocks to watch on Sep 2 [Published Moneycontrol.com - 3 hours ago]
Sensex, Nifty hit fresh record high [Published MyIris - 3 hours ago]
Growth trajectory ahead remains interesting for... [Published MyIris - 3 hours ago]
Cipla jumps on launch of Serroflo in Germany an... [Published MyIris - 3 hours ago]
Pharma stocks gain as rupee edges lower against... [Published Business Standard India - 4 hours ago]
Cipla zooms on entering respiratory market in G... [Published Indian-Commodity - 4 hours ago]
Cipla enters respiratory market in Germany and ... [Published Indian-Commodity - 4 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
SERTRALINE HYDROCHLORIDE Tablet [Cipla Limited] [Published DailyMed Drug Label Updates for the last seven ... - Aug 27 2014]
Updated Date: Aug 27, 2014 EST ...
AMLODIPINE BESYLATE (Amlodipine Besylate Tablet... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
Updated Date: Aug 6, 2014 EST ...
VALACYCLOVIR HYDROCHLORIDE Tablet [Cipla Limited] [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
Updated Date: Aug 5, 2014 EST ...
AMLODIPINE BESYLATE (Amlodipine Besylate Tablet... [Published DailyMed Drug Label Updates for the last seven ... - Aug 06 2014]
Updated Date: Aug 6, 2014 EST ...
VALACYCLOVIR HYDROCHLORIDE Tablet [Cipla Limited] [Published DailyMed Drug Label Updates for the last seven ... - Aug 05 2014]
Updated Date: Aug 5, 2014 EST ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Cipla and BioQuiddity Announce EU Commercial Pa... [Published Financial Services - Jul 31 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.